-
Shanghai Zhudian High-activity IL-15 Pro Cytokine New Product Free Trial
Time of Update: 2022-08-30
The high activity of IL-15 Pro greatly enhances the efficiency of cytokine use and reduces your cell culture costs!In the last issue, we introduced the cytokine IL-2 Pro of Zhudian Bio, which plays an important role in cell therapy, anti-tumor and other fields .
-
Free trial of the new product IL-2 Pro with high solubility and high activity of cytokines
Time of Update: 2022-08-30
The transformation of IL-2 allows IL-2 Pro to have more application scenarios, such as cell therapy research and development, production and as a drug, and has good application prospects in cell culture, drug research and other fields!From now until December 31, 2022, the free trial activity is officially launched.
-
JCO: Professor Qiang Li found that a PRO-based active management model can reduce the symptom
Time of Update: 2022-01-23
This study is the first in the world to verify that the PRO-based active symptom monitoring-warning-feedback whole-process management model can accelerate the postoperative recovery of lung cancer patients, and the patient satisfaction is high; for the first time in the Chinese cultural background and medical system, it is proved that the PRO-based initiative The management model is effective and feasible in the surgical field, which is beneficial to clinical promotion .